EIF4A1 and acute myeloid leukemia: Our results reveal that eIF4A inhibition has a profound effect on the bioenergetic capacity of MOLM-14 AML cells and indicates that eIF4A sustains anabolic metabolism, as outlined above and in the study by Chan et al. [31].